PAYS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient trader. Despite being deeply oversold (RSI ~19) and set up for a short-term bounce, the broader trend and momentum are still bearish (MACD worsening; SMA200 > SMA20 > SMA5) and there is no Intellectia buy signal. I would wait for a clear reclaim of ~4.50 (pivot) or a momentum turn before buying.
Price/levels: Pre-market 4.19 is sitting just below S1 (4.213) with the next support at S2 (4.038). Immediate resistance is the pivot near 4.495, then R1 4.778. Trend: Bearish (SMA_200 > SMA_20 > SMA_5) implying a sustained downtrend. Momentum: MACD histogram -0.0379 and negatively expanding, confirming downside momentum is still strengthening. Overbought/oversold: RSI_6 at 18.97 is extremely oversold, which raises the odds of a reflex bounce, but oversold alone is not a buy trigger when trend/momentum are still deteriorating.
Intellectia Proprietary Trading Signals
Tactical read: A bounce attempt is plausible from ~4.04–4.21 support, but without a signal or a reversal confirmation, buying now is fighting the trend.
Strong recent operating momentum: 2025/Q3 revenue +41.56% YoY, net income +54.17% YoY, EPS +33.33% YoY, and gross margin improvement.
Potential small-cap/undervalued narrative support (recent news mentions opportunities in undervalued smaller stocks that can scale).
Insiders are selling, and selling increased 117.27% over the last month—this is a notable near-term confidence headwind.
Technical downtrend remains intact with worsening MACD; price is below key pivot resistance (~4.50).
No hedge-fund accumulation signal (neutral trend).
Latest reported quarter: 2025/Q3. Growth trends were strong: revenue rose to 21,596,478 (+41.56% YoY), net income to 2,215,135 (+54.17% YoY), EPS to 0.04 (+33.33% YoY), and gross margin improved to 46.12 (+1.86% YoY). This is fundamentally supportive, but the stock’s current tape is not reflecting it yet.
Recent analyst/news signal is limited: only a general mention (Tyler Crowe) highlighting smaller undervalued stocks; no clear rating changes or price target revisions were provided in the data. Wall Street-style pros: strong YoY growth and improving profitability/margins can justify re-rating if momentum continues. Cons: persistent downtrend and heavy insider selling can keep institutions cautious and cap near-term upside.
